Etiology, Risk Factors, and Outcomes of Bacteremia in Patients With Hematologic Malignancies and Febrile Neutropenia in Uganda
Open Access
- 16 November 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (12) , ofae682
Abstract
We determined the etiology, risk factors and outcomes associated with bacteremia in patients with hematologic malignancies and febrile neutropenia (FN) at the Uganda Cancer Institute (UCI). UCI adult and pediatric inpatients with hematologic malignancies and FN were prospectively enrolled and followed up to determine 30-day mortality. Blood drawn from participants with FN was cultured in the BACTEC 9120 blood culture system. Antimicrobial susceptibility testing was performed with the disk diffusion method on identified bacteria. Logistic regression and Cox proportional hazards regression were applied to estimate associations between participant characteristics and FN, bacteremia, and mortality. Of 495 participants, majority (N=306, 62%) were male. Median age was 23 years (IQR:11-42 years). Of the 132 participants who experienced FN, 43 (33%) had bacteremia. Participants with younger age (OR:0.98, p=0.05), severe neutropenia (OR: 2.9, p=0.01), hypotension (OR: 2.46, p=0.04), mucositis (OR: 2.77, p=0.01) and receiving chemotherapy (OR:2.25, p=0.03) were more likely to have bacteremia. Fifty (78%) bacteria isolated were Gram negative. E. coli (n=25, 50%) was predominant. Thirty-seven (86%) out of 43 episodes were caused by multidrug resistant (MDR) bacteria. 30-day overall survival for participants with bacteremia was significantly lower than that for participants with no bacteremia (p=0.05). MDR bacteremia (HR=1.84, p=0.05) was associated with increased risk of death. Bacteremia was frequent in patients with hematologic cancer and FN and was associated with poor survival. MDR bacteria were the main cause of bacteremia and mortality. There is a need for robust infection control and antimicrobial stewardship programs in cancer centers in sub-Saharan Africa.Keywords
Funding Information
- National Institutes of Health (D43 TW009759, ADM 342/411/01)
- Alliance for Global Health and Science Small Grants award
- Center for Emerging and Neglected diseases
- University of California, Berkeley
This publication has 50 references indexed in Scilit:
- Polymicrobial Infection in Patients with Cancer: An Underappreciated and Underreported EntityClinical Infectious Diseases, 2007
- Colonization, Bloodstream Infection, and Mortality Caused by Vancomycin-Resistant Enterococcus Early after Allogeneic Hematopoietic Stem Cell TransplantTransplantation and Cellular Therapy, 2007
- Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsCancer, 2006
- Risk of bacteraemia and mortality in patients with haematological malignanciesClinical Microbiology and Infection, 2006
- Infections in Patients with Febrile Neutropenia: Epidemiology, Microbiology, and Risk StratificationClinical Infectious Diseases, 2005
- Management of Fever in Neutropenic Patients with Different Risks of ComplicationsClinical Infectious Diseases, 2004
- Cotrimoxazole prophylaxis for opportunistic infections in adults with HIVCochrane Database of Systematic Reviews, 2003
- Variation of axillary temperature and its correlation with oral temperature.2000
- Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignanciesJournal of Antimicrobial Chemotherapy, 1998
- Factors predisposing cancer patients to infection1995